TSRI Logo
Cancer Research
Alzheimers Research
Diabetes Research at Scripps
Mental Illness Research
Parkinsons
Addiction Research
Valente article slider
New Research Opens the Door to ‘Functional Cure’ for HIVScientists have for the first time shown that a novel compound effectively suppresses production of the virus in chronically infected cells.
Robbins grant article slider
Scientists Share $9 Million Grant to Develop Therapies that Target the Aging ProcessThe new five-year study focuses on determining the genetic differences between those people who have aged well and those who have not.
Cravatt article slider
TSRI’s Benjamin Cravatt Elected to National Academy of MedicineElection to the Academy is considered one of the highest honors in the fields of health and medicine.
Griffin group photo
Scientists Unveil ‘Roadmap’ to Aid Osteoporosis Treatment Development“Because of our aging population, these kinds of therapeutics are in great demand,” said study leader Patrick R. Griffin.
Ja Sleep study slider
New Study Demonstrates Importance of Studying Sleep and Eating in TandemAn investigation into caffeine consumption sheds light on how diet and sleep interact.
Romesberg slider
Chemists Use Modified DNA Nucleotides to Create New MaterialsThe chemists demonstrated their new approach by making a DNA-based, water-absorbing hydrogel.
Burton Lab Figure
TSRI Study Reveals New Clues to How a Successful HIV Vaccine Could WorkSugar molecules on HIV envelope protein are likely target for future candidate vaccines.
Photo of Matt Tremblay
Calibr and TSRI Executive Matt Tremblay Receives Biocom Catalyst AwardMatt Tremblay, Ph.D., Chief Operating Officer of Calibr and Vice President of Business Development at TSRI, was named one of Biocom Inc.’s annual Life Science Catalyst Award winners.
Basic Biomedical Research
Chemical Studies